Pila Pharma AB Analyst Coverage
ENGLISH
Redeye Equity Research, Sweden (coverage ceased February 28, 2023)
Analyst: Filip Einarsson
Initiation Coverage (December 17, 2021)
Read the report here
Pila Pharma Q1’22: New Project Revealed (April 26, 2022)
Read the report here
Pila Pharma: Adjusting for Capital Injection (May 03, 2022)
Read the report here
Pila Pharma: Tox Studies Initiated (June 30, 2022)
Read the report here
Pila Pharma Q2’22: An Aspiring TRPV1 Platform Company (August 26, 2022)
Read the report here
Pila Pharma: Initial Results from the 13-week safety study (October 12, 2022)
Read the report here
Pila Pharma Q3’22: Funding in Focus (October 26, 2022)
Read the report here
Pila Pharma: Rights Issue Outcome (November 22, 2022)
Read the report here
DANISH
Aktieinfo Analyse, Denmark
Analyst: John Stihøj
Indledende Analyse: Pila Pharma Årsrapport 2023 (April 2, 2024)
Read the report here